APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Device Software Validation

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Medical Device Software Validation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

5 June 2026197 pages

Choose your research edition.

Industry ResearchMedical Device Software Validation Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Device Software Validation Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Medical Device Software Validation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Device Software Validation Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Device Software Validation Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Medical Device Software Validation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Medical Device Software Validation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Device Software Validation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Device Software Validation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Medical Device Software Validation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Medical Device Software Validation include QbD Group, Intertek, SGS, QuEST, TÜV SÜD AG, NAMSA, Element, Eurofins Scientific and Charles River, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Medical Device Software Validation market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Device Software Validation and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Device Software Validation revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Medical Device Software Validation market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Device Software Validation Segment by Company

QbD Group

Intertek

SGS

QuEST

TÜV SÜD AG

NAMSA

Element

Eurofins Scientific

Charles River

Sterling Medical Devices

Pacific Biolabs

Toxikon

Steris Laboratories

Europlaz Technologies

Tata Elxsi

Onyx Healthcare

Medical Device Software Validation Segment by Type

Unit Testing

Integration Testing

System Testing

Others

Medical Device Software Validation Segment by Application

Medical Device Manufacturing

Pharmaceutical

Biotechnology

Research and Development

Medical Device Software Validation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Software Validation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Device Software Validation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Software Validation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Medical Device Software Validation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Device Software Validation industry.

Chapter 3: Detailed analysis of Medical Device Software Validation companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Device Software Validationrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medical Device Software Validation Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Unit Testing Table 3. Key Players of Integration Testing Table 4. Key Players of System Testing Table 3. Key Players of Others Table 4. Global Medical Device Software Validation Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Medical Device Manufacturing Table 6. Key Players of Pharmaceutical Table 7. Key Players of Biotechnology Table 8. Key Players of Research and Development Table 9. Global Medical Device Software Validation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Medical Device Software Validation Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Medical Device Software Validation Market Share by Region (2021-2026) Table 12. Global Medical Device Software Validation Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Medical Device Software Validation Market Share by Region (2027-2032) Table 14. Medical Device Software Validation Industry Trends Table 15. Medical Device Software Validation Industry Drivers Table 16. Medical Device Software Validation Industry Opportunities and Challenges Table 17. Medical Device Software Validation Industry Restraints Table 18. Global Medical Device Software Validation Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Medical Device Software Validation Revenue Market Share by Company (2021-2026) Table 20. Global Medical Device Software Validation Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Medical Device Software Validation Key Company Head Office and Area Served Table 22. Global Medical Device Software Validation Company, Product Type & Application Table 23. Global Medical Device Software Validation Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Medical Device Software Validation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Medical Device Software Validation Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Medical Device Software Validation Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Medical Device Software Validation Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Medical Device Software Validation Revenue Market Share by Type (2021-2026) Table 30. Global Medical Device Software Validation Revenue Market Share by Type (2027-2032) Table 31. Global Medical Device Software Validation Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Medical Device Software Validation Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Medical Device Software Validation Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Medical Device Software Validation Revenue Market Share by Application (2021-2026) Table 35. Global Medical Device Software Validation Revenue Market Share by Application (2027-2032) Table 36. QbD Group Company Information Table 37. QbD Group Business Overview Table 38. QbD Group Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. QbD Group Medical Device Software Validation Product Portfolio Table 40. QbD Group Recent Development Table 41. Intertek Company Information Table 42. Intertek Business Overview Table 43. Intertek Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Intertek Medical Device Software Validation Product Portfolio Table 45. Intertek Recent Development Table 46. SGS Company Information Table 47. SGS Business Overview Table 48. SGS Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. SGS Medical Device Software Validation Product Portfolio Table 50. SGS Recent Development Table 51. QuEST Company Information Table 52. QuEST Business Overview Table 53. QuEST Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. QuEST Medical Device Software Validation Product Portfolio Table 55. QuEST Recent Development Table 56. TÜV SÜD AG Company Information Table 57. TÜV SÜD AG Business Overview Table 58. TÜV SÜD AG Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. TÜV SÜD AG Medical Device Software Validation Product Portfolio Table 60. TÜV SÜD AG Recent Development Table 61. NAMSA Company Information Table 62. NAMSA Business Overview Table 63. NAMSA Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. NAMSA Medical Device Software Validation Product Portfolio Table 65. NAMSA Recent Development Table 66. Element Company Information Table 67. Element Business Overview Table 68. Element Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Element Medical Device Software Validation Product Portfolio Table 70. Element Recent Development Table 71. Eurofins Scientific Company Information Table 72. Eurofins Scientific Business Overview Table 73. Eurofins Scientific Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Eurofins Scientific Medical Device Software Validation Product Portfolio Table 75. Eurofins Scientific Recent Development Table 76. Charles River Company Information Table 77. Charles River Business Overview Table 78. Charles River Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Charles River Medical Device Software Validation Product Portfolio Table 80. Charles River Recent Development Table 81. Sterling Medical Devices Company Information Table 82. Sterling Medical Devices Business Overview Table 83. Sterling Medical Devices Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Sterling Medical Devices Medical Device Software Validation Product Portfolio Table 85. Sterling Medical Devices Recent Development Table 86. Pacific Biolabs Company Information Table 87. Pacific Biolabs Business Overview Table 88. Pacific Biolabs Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Pacific Biolabs Medical Device Software Validation Product Portfolio Table 90. Pacific Biolabs Recent Development Table 91. Toxikon Company Information Table 92. Toxikon Business Overview Table 93. Toxikon Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Toxikon Medical Device Software Validation Product Portfolio Table 95. Toxikon Recent Development Table 96. Steris Laboratories Company Information Table 97. Steris Laboratories Business Overview Table 98. Steris Laboratories Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Steris Laboratories Medical Device Software Validation Product Portfolio Table 100. Steris Laboratories Recent Development Table 101. Europlaz Technologies Company Information Table 102. Europlaz Technologies Business Overview Table 103. Europlaz Technologies Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Europlaz Technologies Medical Device Software Validation Product Portfolio Table 105. Europlaz Technologies Recent Development Table 106. Tata Elxsi Company Information Table 107. Tata Elxsi Business Overview Table 108. Tata Elxsi Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Tata Elxsi Medical Device Software Validation Product Portfolio Table 110. Tata Elxsi Recent Development Table 111. Onyx Healthcare Company Information Table 112. Onyx Healthcare Business Overview Table 113. Onyx Healthcare Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Onyx Healthcare Medical Device Software Validation Product Portfolio Table 115. Onyx Healthcare Recent Development Table 116. North America Medical Device Software Validation Market Size by Type (2021-2026) & (US$ Million) Table 117. North America Medical Device Software Validation Market Size by Type (2027-2032) & (US$ Million) Table 118. North America Medical Device Software Validation Market Size by Application (2021-2026) & (US$ Million) Table 119. North America Medical Device Software Validation Market Size by Application (2027-2032) & (US$ Million) Table 120. North America Medical Device Software Validation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Medical Device Software Validation Market Size by Country (2021-2026) Table 122. North America Medical Device Software Validation Market Size by Country (2027-2032) Table 123. Europe Medical Device Software Validation Market Size by Type (2021-2026) & (US$ Million) Table 124. Europe Medical Device Software Validation Market Size by Type (2027-2032) & (US$ Million) Table 125. Europe Medical Device Software Validation Market Size by Application (2021-2026) & (US$ Million) Table 126. Europe Medical Device Software Validation Market Size by Application (2027-2032) & (US$ Million) Table 127. Europe Medical Device Software Validation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Medical Device Software Validation Market Size by Country (2021-2026) Table 129. Europe Medical Device Software Validation Market Size by Country (2027-2032) Table 130. China Medical Device Software Validation Market Size by Type (2021-2026) & (US$ Million) Table 131. China Medical Device Software Validation Market Size by Type (2027-2032) & (US$ Million) Table 132. China Medical Device Software Validation Market Size by Application (2021-2026) & (US$ Million) Table 133. China Medical Device Software Validation Market Size by Application (2027-2032) & (US$ Million) Table 134. Asia Medical Device Software Validation Market Size by Type (2021-2026) & (US$ Million) Table 135. Asia Medical Device Software Validation Market Size by Type (2027-2032) & (US$ Million) Table 136. Asia Medical Device Software Validation Market Size by Application (2021-2026) & (US$ Million) Table 137. Asia Medical Device Software Validation Market Size by Application (2027-2032) & (US$ Million) Table 138. Asia Medical Device Software Validation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Medical Device Software Validation Market Size by Country (2021-2026) Table 140. Asia Medical Device Software Validation Market Size by Country (2027-2032) Table 141. South America, Middle East & Africa Medical Device Software Validation Market Size by Type (2021-2026) & (US$ Million) Table 142. South America, Middle East & Africa Medical Device Software Validation Market Size by Type (2027-2032) & (US$ Million) Table 143. South America, Middle East & Africa Medical Device Software Validation Market Size by Application (2021-2026) & (US$ Million) Table 144. South America, Middle East & Africa Medical Device Software Validation Market Size by Application (2027-2032) & (US$ Million) Table 145. South America, Middle East & Africa Medical Device Software Validation Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. South America, Middle East & Africa Medical Device Software Validation Market Size by Country (2021-2026) Table 147. South America, Middle East & Africa Medical Device Software Validation Market Size by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Medical Device Software Validation Product Image Figure 2. Global Medical Device Software Validation Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Medical Device Software Validation Market Share by Type: 2025 VS 2032 Figure 4. Unit Testing Image Figure 5. Integration Testing Image Figure 6. System Testing Image Figure 7. Others Image Figure 8. Global Medical Device Software Validation Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Medical Device Software Validation Market Share by Application: 2025 VS 2032 Figure 10. Medical Device Manufacturing Image Figure 11. Pharmaceutical Image Figure 12. Biotechnology Image Figure 13. Research and Development Image Figure 14. Global Medical Device Software Validation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 16. Global Medical Device Software Validation Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Medical Device Software Validation Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Medical Device Software Validation Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Medical Device Software Validation Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Medical Device Software Validation Revenue Market Share by Type (2021-2032) Figure 23. Global Medical Device Software Validation Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Medical Device Software Validation Revenue Market Share by Application (2021-2032) Figure 25. North America Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 26. North America Medical Device Software Validation Market Share by Type (2021-2032) Figure 27. North America Medical Device Software Validation Market Share by Application (2021-2032) Figure 28. North America Medical Device Software Validation Market Share by Country (2021-2032) Figure 29. United States Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 30. Canada Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 32. Europe Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 33. Europe Medical Device Software Validation Market Share by Type (2021-2032) Figure 34. Europe Medical Device Software Validation Market Share by Application (2021-2032) Figure 35. Europe Medical Device Software Validation Market Share by Country (2021-2032) Figure 36. Germany Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 37. France Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 39. Italy Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 40. Russia Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 42. China Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 43. China Medical Device Software Validation Market Share by Type (2021-2032) Figure 44. China Medical Device Software Validation Market Share by Application (2021-2032) Figure 45. Asia Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 46. Asia Medical Device Software Validation Market Share by Type (2021-2032) Figure 47. Asia Medical Device Software Validation Market Share by Application (2021-2032) Figure 48. Asia Medical Device Software Validation Market Share by Country (2021-2032) Figure 49. Japan Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 53. India Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 54. Australia Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Medical Device Software Validation Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Medical Device Software Validation Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Medical Device Software Validation Market Share by Country (2021-2032) Figure 59. Brazil Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 64. UAE Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 66. Chile Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Unit Testing
  • Integration Testing
  • System Testing
  • Others
Applications
  • Medical Device Manufacturing
  • Pharmaceutical
  • Biotechnology
  • Research and Development
Companies covered
  • QbD Group
  • Intertek
  • SGS
  • QuEST
  • TÜV SÜD AG
  • NAMSA
  • Element
  • Eurofins Scientific
  • Charles River
  • Sterling Medical Devices
  • Pacific Biolabs
  • Toxikon
  • Steris Laboratories
  • Europlaz Technologies
  • Tata Elxsi
  • Onyx Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Medical Device Software Validation Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Unit Testing
  5. 1.2.3 Integration Testing
  6. 1.2.4 System Testing
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Medical Device Software Validation Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Medical Device Manufacturing
  11. 1.3.3 Pharmaceutical
  12. 1.3.4 Biotechnology
  13. 1.3.5 Research and Development
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Medical Device Software Validation Growth Trends by Region
  16. 1.5.1 Global Medical Device Software Validation Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Medical Device Software Validation Market Size by Region (2021-2026)
  18. 1.5.3 Medical Device Software Validation Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Medical Device Software Validation Market Dynamics
  1. 2.1 Medical Device Software Validation Industry Trends
  2. 2.2 Medical Device Software Validation Industry Drivers
  3. 2.3 Medical Device Software Validation Industry Opportunities and Challenges
  4. 2.4 Medical Device Software Validation Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Medical Device Software Validation Revenue by Company (2021-2026)
  2. 3.2 Global Medical Device Software Validation Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Medical Device Software Validation Key Company Head office and Area Served
  4. 3.4 Global Medical Device Software Validation Company, Product Type & Application
  5. 3.5 Global Medical Device Software Validation Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Medical Device Software Validation Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Medical Device Software Validation Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Medical Device Software Validation Tier 1, Tier 2, and Tier 3
4 Medical Device Software Validation Market by Type
  1. 4.1 Global Medical Device Software Validation Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Medical Device Software Validation Market Size by Type (2021-2032)
  3. 4.3 Global Medical Device Software Validation Market Size Share by Type (2021-2032)
5 Medical Device Software Validation Market by Application
  1. 5.1 Global Medical Device Software Validation Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Medical Device Software Validation Market Size by Application (2021-2032)
  3. 5.3 Global Medical Device Software Validation Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 QbD Group
  2. 6.1.1 QbD Group Company Information
  3. 6.1.2 QbD Group Business Overview
  4. 6.1.3 QbD Group Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 QbD Group Medical Device Software Validation Product Portfolio
  6. 6.1.5 QbD Group Recent Developments
  7. 6.2 Intertek
  8. 6.2.1 Intertek Company Information
  9. 6.2.2 Intertek Business Overview
  10. 6.2.3 Intertek Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Intertek Medical Device Software Validation Product Portfolio
  12. 6.2.5 Intertek Recent Developments
  13. 6.3 SGS
  14. 6.3.1 SGS Company Information
  15. 6.3.2 SGS Business Overview
  16. 6.3.3 SGS Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 SGS Medical Device Software Validation Product Portfolio
  18. 6.3.5 SGS Recent Developments
  19. 6.4 QuEST
  20. 6.4.1 QuEST Company Information
  21. 6.4.2 QuEST Business Overview
  22. 6.4.3 QuEST Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 QuEST Medical Device Software Validation Product Portfolio
  24. 6.4.5 QuEST Recent Developments
  25. 6.5 TÜV SÜD AG
  26. 6.5.1 TÜV SÜD AG Company Information
  27. 6.5.2 TÜV SÜD AG Business Overview
  28. 6.5.3 TÜV SÜD AG Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 TÜV SÜD AG Medical Device Software Validation Product Portfolio
  30. 6.5.5 TÜV SÜD AG Recent Developments
  31. 6.6 NAMSA
  32. 6.6.1 NAMSA Company Information
  33. 6.6.2 NAMSA Business Overview
  34. 6.6.3 NAMSA Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 NAMSA Medical Device Software Validation Product Portfolio
  36. 6.6.5 NAMSA Recent Developments
  37. 6.7 Element
  38. 6.7.1 Element Company Information
  39. 6.7.2 Element Business Overview
  40. 6.7.3 Element Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Element Medical Device Software Validation Product Portfolio
  42. 6.7.5 Element Recent Developments
  43. 6.8 Eurofins Scientific
  44. 6.8.1 Eurofins Scientific Company Information
  45. 6.8.2 Eurofins Scientific Business Overview
  46. 6.8.3 Eurofins Scientific Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Eurofins Scientific Medical Device Software Validation Product Portfolio
  48. 6.8.5 Eurofins Scientific Recent Developments
  49. 6.9 Charles River
  50. 6.9.1 Charles River Company Information
  51. 6.9.2 Charles River Business Overview
  52. 6.9.3 Charles River Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Charles River Medical Device Software Validation Product Portfolio
  54. 6.9.5 Charles River Recent Developments
  55. 6.10 Sterling Medical Devices
  56. 6.10.1 Sterling Medical Devices Company Information
  57. 6.10.2 Sterling Medical Devices Business Overview
  58. 6.10.3 Sterling Medical Devices Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Sterling Medical Devices Medical Device Software Validation Product Portfolio
  60. 6.10.5 Sterling Medical Devices Recent Developments
  61. 6.11 Pacific Biolabs
  62. 6.11.1 Pacific Biolabs Company Information
  63. 6.11.2 Pacific Biolabs Business Overview
  64. 6.11.3 Pacific Biolabs Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Pacific Biolabs Medical Device Software Validation Product Portfolio
  66. 6.11.5 Pacific Biolabs Recent Developments
  67. 6.12 Toxikon
  68. 6.12.1 Toxikon Company Information
  69. 6.12.2 Toxikon Business Overview
  70. 6.12.3 Toxikon Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Toxikon Medical Device Software Validation Product Portfolio
  72. 6.12.5 Toxikon Recent Developments
  73. 6.13 Steris Laboratories
  74. 6.13.1 Steris Laboratories Company Information
  75. 6.13.2 Steris Laboratories Business Overview
  76. 6.13.3 Steris Laboratories Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Steris Laboratories Medical Device Software Validation Product Portfolio
  78. 6.13.5 Steris Laboratories Recent Developments
  79. 6.14 Europlaz Technologies
  80. 6.14.1 Europlaz Technologies Company Information
  81. 6.14.2 Europlaz Technologies Business Overview
  82. 6.14.3 Europlaz Technologies Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Europlaz Technologies Medical Device Software Validation Product Portfolio
  84. 6.14.5 Europlaz Technologies Recent Developments
  85. 6.15 Tata Elxsi
  86. 6.15.1 Tata Elxsi Company Information
  87. 6.15.2 Tata Elxsi Business Overview
  88. 6.15.3 Tata Elxsi Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Tata Elxsi Medical Device Software Validation Product Portfolio
  90. 6.15.5 Tata Elxsi Recent Developments
  91. 6.16 Onyx Healthcare
  92. 6.16.1 Onyx Healthcare Company Information
  93. 6.16.2 Onyx Healthcare Business Overview
  94. 6.16.3 Onyx Healthcare Medical Device Software Validation Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Onyx Healthcare Medical Device Software Validation Product Portfolio
  96. 6.16.5 Onyx Healthcare Recent Developments
7 North America
  1. 7.1 North America Medical Device Software Validation Market Size (2021-2032)
  2. 7.2 North America Medical Device Software Validation Market Size by Type
  3. 7.2.1 North America Medical Device Software Validation Market Size by Type (2021-2026)
  4. 7.2.2 North America Medical Device Software Validation Market Size by Type (2027-2032)
  5. 7.2.3 North America Medical Device Software Validation Market Share by Type (2021-2032)
  6. 7.3 North America Medical Device Software Validation Market Size by Application
  7. 7.3.1 North America Medical Device Software Validation Market Size by Application (2021-2026)
  8. 7.3.2 North America Medical Device Software Validation Market Size by Application (2027-2032)
  9. 7.3.3 North America Medical Device Software Validation Market Share by Application (2021-2032)
  10. 7.4 North America Medical Device Software Validation Market Size by Country
  11. 7.4.1 North America Medical Device Software Validation Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Medical Device Software Validation Market Size by Country (2021-2026)
  13. 7.4.3 North America Medical Device Software Validation Market Size by Country (2027-2032)
  14. 7.4.4 North America Medical Device Software Validation Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Medical Device Software Validation Market Size (2021-2032)
  2. 8.2 Europe Medical Device Software Validation Market Size by Type
  3. 8.2.1 Europe Medical Device Software Validation Market Size by Type (2021-2026)
  4. 8.2.2 Europe Medical Device Software Validation Market Size by Type (2027-2032)
  5. 8.2.3 Europe Medical Device Software Validation Market Share by Type (2021-2032)
  6. 8.3 Europe Medical Device Software Validation Market Size by Application
  7. 8.3.1 Europe Medical Device Software Validation Market Size by Application (2021-2026)
  8. 8.3.2 Europe Medical Device Software Validation Market Size by Application (2027-2032)
  9. 8.3.3 Europe Medical Device Software Validation Market Share by Application (2021-2032)
  10. 8.4 Europe Medical Device Software Validation Market Size by Country
  11. 8.4.1 Europe Medical Device Software Validation Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Medical Device Software Validation Market Size by Country (2021-2026)
  13. 8.4.3 Europe Medical Device Software Validation Market Size by Country (2027-2032)
  14. 8.4.4 Europe Medical Device Software Validation Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Medical Device Software Validation Market Size (2021-2032)
  2. 9.2 China Medical Device Software Validation Market Size by Type
  3. 9.2.1 China Medical Device Software Validation Market Size by Type (2021-2026)
  4. 9.2.2 China Medical Device Software Validation Market Size by Type (2027-2032)
  5. 9.2.3 China Medical Device Software Validation Market Share by Type (2021-2032)
  6. 9.3 China Medical Device Software Validation Market Size by Application
  7. 9.3.1 China Medical Device Software Validation Market Size by Application (2021-2026)
  8. 9.3.2 China Medical Device Software Validation Market Size by Application (2027-2032)
  9. 9.3.3 China Medical Device Software Validation Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Medical Device Software Validation Market Size (2021-2032)
  2. 10.2 Asia Medical Device Software Validation Market Size by Type
  3. 10.2.1 Asia Medical Device Software Validation Market Size by Type (2021-2026)
  4. 10.2.2 Asia Medical Device Software Validation Market Size by Type (2027-2032)
  5. 10.2.3 Asia Medical Device Software Validation Market Share by Type (2021-2032)
  6. 10.3 Asia Medical Device Software Validation Market Size by Application
  7. 10.3.1 Asia Medical Device Software Validation Market Size by Application (2021-2026)
  8. 10.3.2 Asia Medical Device Software Validation Market Size by Application (2027-2032)
  9. 10.3.3 Asia Medical Device Software Validation Market Share by Application (2021-2032)
  10. 10.4 Asia Medical Device Software Validation Market Size by Country
  11. 10.4.1 Asia Medical Device Software Validation Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Medical Device Software Validation Market Size by Country (2021-2026)
  13. 10.4.3 Asia Medical Device Software Validation Market Size by Country (2027-2032)
  14. 10.4.4 Asia Medical Device Software Validation Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Medical Device Software Validation Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Medical Device Software Validation Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Medical Device Software Validation Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Medical Device Software Validation Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Medical Device Software Validation Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Medical Device Software Validation Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Medical Device Software Validation Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Medical Device Software Validation Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Medical Device Software Validation Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Medical Device Software Validation Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Medical Device Software Validation Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Medical Device Software Validation Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Medical Device Software Validation Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Medical Device Software Validation Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst